US Patent Issued to Alpine Immune Sciences on May 12 for "CD155 variant immunomodulatory proteins and uses thereof" (Washington Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,087, issued on May 12, was assigned to Alpine Immune Sciences Inc. (Seattle).

"CD155 variant immunomodulatory proteins and uses thereof" was invented by Ryan Swanson (Seattle), Michael Kornacker (Seattle), Daniel William Demonte (Seattle) and Mark F. Maurer (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are immunomodulatory proteins comprising variant CD155 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided."

The patent was filed on Oct. 14, 2022,...